This article refers to 'Prevention of the development of heart failure with preserved ejection fraction by the phosphodiesterase-5A inhibitor vardenafil in rats with type 2 diabetes,' by C.Matyas et al., published in this issue on pages 326-336.

Phosphodiesterase-5 inhibition in heart failure with preserved ejection fraction : trading therapy for prevention / M. Guazzi, L. van Heerebeek, W.J. Paulus. - In: EUROPEAN JOURNAL OF HEART FAILURE. - ISSN 1388-9842. - 19:3(2017 Mar), pp. 337-339. [10.1002/ejhf.742]

Phosphodiesterase-5 inhibition in heart failure with preserved ejection fraction : trading therapy for prevention

M. Guazzi;
2017

Abstract

This article refers to 'Prevention of the development of heart failure with preserved ejection fraction by the phosphodiesterase-5A inhibitor vardenafil in rats with type 2 diabetes,' by C.Matyas et al., published in this issue on pages 326-336.
Settore MED/11 - Malattie dell'Apparato Cardiovascolare
mar-2017
Article (author)
File in questo prodotto:
File Dimensione Formato  
Guazzi_et_al-2017-European_Journal_of_Heart_Failure.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 152.24 kB
Formato Adobe PDF
152.24 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/473087
Citazioni
  • ???jsp.display-item.citation.pmc??? 4
  • Scopus 7
  • ???jsp.display-item.citation.isi??? 8
social impact